| 1. |
Reddy DL, Nel J, Govender NP. Review: Emergomycosis. J Mycol Med, 2023, 33(1): 101313.
|
| 2. |
Hoenigl M, Salmanton-Garcia J, Walsh T J, et al. Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology. Lancet Infect Dis, 2021, 21(8): e246-e257.
|
| 3. |
Schwartz IS, Govender NP, Corcoran C, et al. Clinical characteristics, diagnosis, management, and outcomes of disseminated emmonsiosis: a retrospective case series. Clin Infect Dis, 2015, 61(6): 1004-1012.
|
| 4. |
Samaddar A, Sharma A. Emergomycosis, an emerging systemic mycosis in immunocompromised patients: current trends and future prospects. Front Med (Lausanne), 2021, 8: 670731.
|
| 5. |
Dukik K, Munoz JF, Jiang Y, et al. Novel taxa of thermally dimorphic systemic pathogens in the Ajellomycetaceae (Onygenales). Mycoses, 2017, 60(5): 296-309.
|
| 6. |
王佳美, 顧彧, 宋夢月, 等. 慢性阻塞性肺疾病合并不同類型肺曲霉病臨床研究進展. 中國呼吸與危重監護雜志, 2024, 23(1): 53-59.
|
| 7. |
Spallone A, Schwartz IS. Emerging Fungal Infections. Infect Dis Clin North Am, 2021, 35(2): 261-277.
|
| 8. |
Thompson GR, Le T, Chindamporn A, et al. Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology. Lancet Infect Dis, 2021, 21(12): e364-e374.
|
| 9. |
魯秦陽, 劉善收, 羅恒, 等. 急診ICU 226例患者肺部真菌感染危險因素及防護策略研究. 創傷與急危重病醫學, 2024, 12(2): 70-73.
|
| 10. |
Malik R, Capoor MR, Vanidassane I, et al. Disseminated Emmonsia pasteuriana infection in India: a case report and a review. Mycoses, 2016, 59(2): 127-132.
|
| 11. |
Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis, 2005, 41(5): 654-659.
|
| 12. |
Gast KB, van der Hoeven A, de Boer M, et al. Two cases of Emergomyces pasteurianus infection in immunocompromised patients in the Netherlands. Med Mycol Case Rep, 2019, 24: 5-8.
|
| 13. |
Bloos F, Held J, Kluge S, et al. (1 -->3)-beta-D-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial. Intensive Care Med, 2022, 48(7): 865-875.
|
| 14. |
Howell SA. Dermatopathology and the diagnosis of fungal infections. Br J Biomed Sci, 2023, 80: 11314.
|
| 15. |
Schwartz IS, Govender NP, Sigler L, et al. Emergomyces: The global rise of new dimorphic fungal pathogens. PLoS Pathog, 2019, 15(9): e1007977.
|
| 16. |
李翔, 陳海云, 付旭文, 等. 艾滋病合并腸道馬爾尼菲籃狀菌感染1例. 傳染病信息, 2024, 37(4): 381-384.
|
| 17. |
劉富菁, 靳雪楊, 常文強. 抗真菌靶標及潛在抗真菌藥物的發現. 國外醫藥(抗生素分冊), 2024, 45(6): 361-372.
|
1/5
WeChat